Benzinga | Jan 7, 2022 01:09PM EST

Rockwell Medical To Present At H.C. Wainwright BioConnect 2022 Conference On Jan. 10 At 7 a.m. EST

Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced the Rockwell Medical executive management team is scheduled to present at the H.C. Wainwright BioConnect 2022 Conference.



The presentation will become publicly available for on-demand listening beginning on Monday, January 10 at 7:00 a.m. Eastern Time in the "Investors" section of the Company's website at www.rockwellmed.com. A replay of the webcast will be archived on the Company's website for 90 days.